A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

This study is exploring whether myeloma patients can safely and effectively give themselves bortezomib (a cancer drug) injections at home — after being taught by clinic staff — instead of always coming into a hospital or cancer center for each injection. **You may be eligible if:** - You are 18 or older with symptomatic multiple myeloma - Your condition is clinically stable as determined by your doctor - You (or a caregiver) are willing and considered capable of self-administering injections after training - You have already received more than 4 bortezomib injections in a hospital or cancer center **You may NOT be eligible if:** - You are currently participating in another trial that includes bortezomib - You have had an allergic reaction to bortezomib - You have had grade 3 or worse side effects from bortezomib in the past - You have had significant bleeding linked to bortezomib - Your life expectancy is very short or you are unlikely to comply with therapy Talk to your doctor to see if this trial is right for you.